Development of diagnostic method for colon cancer using mutational analyses of tumor tissues and plasma
Not Applicable
Completed
- Conditions
- Neoplasms
- Registration Number
- KCT0008037
- Lead Sponsor
- EONE-DIAGNOMICS GENOME CENTER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 350
Inclusion Criteria
1. Patients aged 18 years or older (male and female) diagnosed with colorectal cancer
2. Patients whose residual tumor is confirmed to be larger than 1cm in diameter after the removed tumor is used for diagnostic purposes
3. When both cancer tissue and plasma can be collected
4. Sign the consent form
5. Patients who are willing to perform all trial-related procedures within the clinical trial period
Exclusion Criteria
1. If only biopsy is performed
2. In case of accompanying other carcinoma
3. If the patient does not consent
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ctDNA Efficiency Assessment, Checking the type and frequency of mutations
- Secondary Outcome Measures
Name Time Method ot applicable